tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

RIGL Stock Latest News

Rigel Pharmaceuticals resolves patent litigation related to Tavalisse
The FlyRigel Pharmaceuticals resolves patent litigation related to Tavalisse
1M ago
RIGL
Rigel Pharmaceuticals Appoints Dr. Frohlich to Board
PremiumCompany Announcements
Rigel Pharmaceuticals Appoints Dr. Frohlich to Board
2M ago
8K
RIGL
Rigel Pharmaceuticals price target raised to $55 from $49 at Citi
PremiumThe Fly
Rigel Pharmaceuticals price target raised to $55 from $49 at Citi
2M ago
RIGL
Rigel Pharmaceuticals Implements 1-for-10 Reverse Stock Split: Balancing Nasdaq Compliance and Investor Appeal
PremiumCompany Announcements
Rigel Pharmaceuticals Implements 1-for-10 Reverse Stock Split: Balancing Nasdaq Compliance and Investor Appeal
2M ago
RIGL
Rigel Pharmaceuticals Reports Record Sales and Strategic Growth
PremiumCompany Announcements
Rigel Pharmaceuticals Reports Record Sales and Strategic Growth
2M ago
RIGL
Rigel Pharmaceuticals price target raised to $24 from $20 at B. Riley
PremiumThe FlyRigel Pharmaceuticals price target raised to $24 from $20 at B. Riley
2M ago
RIGL
Rigel’s Promising Financial Performance and Strategic Growth Initiatives Drive Buy Rating
Premium
Ratings
Rigel’s Promising Financial Performance and Strategic Growth Initiatives Drive Buy Rating
2M ago
RIGL
Rigel Pharmaceuticals Reports Strong 2024 Financial Results
Premium
Company Announcements
Rigel Pharmaceuticals Reports Strong 2024 Financial Results
2M ago
RIGL
Rigel Pharmaceuticals reports Q4 EPS 80c, consensus 58c
PremiumThe Fly
Rigel Pharmaceuticals reports Q4 EPS 80c, consensus 58c
2M ago
RIGL
Rigel Pharmaceuticals sees FY25 revenue $200M-$210M, consensus $204.88M
PremiumThe Fly
Rigel Pharmaceuticals sees FY25 revenue $200M-$210M, consensus $204.88M
2M ago
RIGL
RIGL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
RIGL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
RIGL
Rigel Pharmaceuticals enrolls first patient in Phase 1 study of fostamatinib
PremiumThe Fly
Rigel Pharmaceuticals enrolls first patient in Phase 1 study of fostamatinib
3M ago
RIGL
Rigel Pharmaceuticals sees Q4 revenue $57.6M, consensus $47.42M
PremiumThe FlyRigel Pharmaceuticals sees Q4 revenue $57.6M, consensus $47.42M
3M ago
RIGL
Rigel Pharmaceuticals sees FY25 revenue $200M-$210M, consensus $193.51M
Premium
The Fly
Rigel Pharmaceuticals sees FY25 revenue $200M-$210M, consensus $193.51M
3M ago
RIGL
Rigel announces R289 granted Orphan Drug designation by FDA for MDS
Premium
The Fly
Rigel announces R289 granted Orphan Drug designation by FDA for MDS
4M ago
RIGL
Rigel granted orphan status for myelodysplastic syndromes treatment
PremiumThe Fly
Rigel granted orphan status for myelodysplastic syndromes treatment
4M ago
RIGL
Rigel Pharmaceuticals price target raised to $25 from $15 at Cantor Fitzgerald
PremiumThe Fly
Rigel Pharmaceuticals price target raised to $25 from $15 at Cantor Fitzgerald
5M ago
RIGL
Rigel Pharmaceuticals price target lowered to $20 from $27 at B. Riley
PremiumThe Fly
Rigel Pharmaceuticals price target lowered to $20 from $27 at B. Riley
5M ago
RIGL
Rigel Pharmaceuticals announces initial data from Phase 1b study of R289
PremiumThe Fly
Rigel Pharmaceuticals announces initial data from Phase 1b study of R289
5M ago
RIGL
Rigel Pharmaceuticals price target raised to $27 from $17 at B. Riley
PremiumThe FlyRigel Pharmaceuticals price target raised to $27 from $17 at B. Riley
5M ago
RIGL
Rigel Pharmaceuticals announces R289 granted Fast Track designation by FDA
Premium
The Fly
Rigel Pharmaceuticals announces R289 granted Fast Track designation by FDA
5M ago
RIGL
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
RNA
AGEN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >